A human monoclonal antibody against hepatitis B surface antigen with potent neutralizing activity

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Cerino, Antonella ^a   Bremer, Corinna M ^b   Glebe, Dieter ^b   Mondelli, Mario U ^a,c  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAG PROTEIN; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY ADRI 2F3; MONOCLONAL ANTIBODY PK10C7; MONOCLONAL ANTIBODY PK3D1; UNCLASSIFIED DRUG; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY;

ACUTE HEPATITIS B; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; INOCULATION; LIVER CELL; MOLECULAR CLONING; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; REINFECTION; SCANDENTIA; TUPAIA BELANGERI; VIRUS NEUTRALIZATION; VIRUS PARTICLE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; IMMUNOLOGY; LIVER TRANSPLANTATION; MONONUCLEAR CELL; VIROLOGY;

EUKARYOTA; HEPATITIS B VIRUS; TUPAIA BELANGERI;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATOCYTES; HUMANS; IMMUNOGLOBULIN G; LEUKOCYTES, MONONUCLEAR; LIVER TRANSPLANTATION;

EID: 84928817570     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125704     Document Type: Article

References (24)

1. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 2005; 34: S1-S3. PMID: 16461234
2. World Health Organization (WHO). Hepatitis B: WHO fact sheet on Hepatitis B providing key facts and information. Fact sheet N° 204. Updated March 2015 Available: http://www.who.int/mediacentre/factsheets/fs204/en/.
3. Allain JP, Candotti D; ISBT HBV Safety Collaborative Group. (2012) Hepatitis B virus in transfusion medicine: still a problem? Biologicals. 2012; 40:180-186. doi: 10.1016/j.biologicals.2011.09.014 PMID: 22305086
4. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med. 1997; 336: 1855-1859. PMID: 9197213
5. Fox AN, Terrault NA. The option of HBIG-free prophylaxis against recurrent HBV. J Hepatol. 2012; 56: 1189-1197. doi: 10.1016/j.jhep.2011.08.026 PMID: 22274310
6. Shouval D, Samuel D. Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a concise review. Hepatology 2000; 32: 1189-1195. PMID: 11093723
7. Schilling R, Ijaz S, Davidoff M, Lee JY, Locarnini S, Williams R, et al. Endocytosis of hepatitis B immune globulin into hepatocytes inhibits the secretion of hepatitis B virus surface antigen and virions. J Virol 2003; 77: 8882-8892. PMID: 12885906
8. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993; 329: 1842-1847. PMID: 8247035
9. Terrault NA, Zhou S, McCory RW, Pruett TL, Lake JR, Roberts JP, et al. Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology 1998; 28: 555-561. PMID: 9696024
10. Traggiai E, Becker S, Subbarao K, Kolesnikova L, Uematsu Y, Gismondo MR, et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med 2005; 10: 871-875.
11. Cerino A, Mondelli MU. Identification of an immunodominant B-cell epitope on the hepatitis C virus nonstructural region defined by human monoclonal antibodies. J Immunol 1991; 147: 2692-2696. PMID: 1717573
12. Cerino A, Boender P, Rosa C, La Monica N, Habets W, Mondelli MU. A human monoclonal antibody specific for the N-terminus of hepatitis C virus nucleocapsid protein. J Immunol 1993; 151: 7005-7015. PMID: 7505020
13. Mondelli MU, Cerino A, Boender P, Oudshoorn P, Middeldorp J, Fipaldini C, et al. Significance of the immune response to a major, conformational B cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody. J Virol 1994; 68: 4829-4836. PMID: 7518528
14. Mondelli MU, Cerino A. Production of anti-HCV by human B cell clones and their characterization. In: Lau JYN, Ed., "Hepatitis C Protocols", Methods in Molecular Medicine, The Humana Press Inc., Totowa U.S.A. 1998, p. 451-461.
15. Bremer CM, Sominskaya I, Skrastina D, Pumpens P, Abd El Wahed A, Beutling U, et al. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus. J Hepatol 2011; 55: 29-37. doi: 10.1016/j.jhep.2010.10.019 PMID: 21145866
16. Walter E, Keist R, Niederost B, Pult I, Blum HE. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology 1996; 24: 1-5. PMID: 8707245
17. Ueda K, Tsurimoto T, Matsubara K. Three envelope proteins of hepatitis B virus: large S, middle S, and major S proteins needed for the formation of Dane particles. J Virol 1991; 65: 3521-3529. PMID: 2041079
18. Eren R, Ilan E, Nussbaum O, Lubin I, Terkieltaub D, Arazi Y, et al. Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and the HBV chronic carrier chimpanzees. Hepatology 2000; 32: 588-596. PMID: 10960454
19. Tajiri K, Ozawa T, Jin A, Tokimitsu Y, Minemura M, Kishi H, et al. Analysis of the epitope and neutralizing capacity of human monoclonal antibodies by hepatitis B vaccine. Antivir Res. 2010; 87: 40-49. doi: 10.1016/j.antiviral.2010.04.006 PMID: 20412816
20. Shin YW, Ryoo KH, Hong KW, Chang KH, Choi JS, So M, et al. Human monoclonal antibody against Hepatitis B virus surface antigen (HBsAg). Antivir Res. 2007; 75: 113-120. PMID: 17343928
21. Kim SH, Shin YW, Hong KW, Chang KH, Ryoo KH, Paik SH, et al. Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees. Antivir Res 2008; 79: 188-191. doi: 10.1016/j.antiviral.2008.03.006 PMID: 18479762
22. Romanò L, Paladini S, Galli C, Raimondo G, Pollicino T, Zanetti AR. Hepatitis B vaccination. Hum Vaccin Immunother 2015; 11: 53-7. doi: 10.4161/hv.34306 PMID: 25483515
23. Ishigami M, Honda T, Ishizu Y, Onishi Y, Kamei H, Hayashi K, et al. Frequent incidence of escape mutants after successful hepatitis B vaccine response and stopping of nucleos(t)ide analogues in liver transplant recipients. Liver Transpl 2014; 20: 1211-20. doi: 10.1002/lt.23935 PMID: 24961506
24. Davenport FM, Hennessy AV, Francis T. Jr. Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. J Exp Med 1953; 98: 641-656. PMID: 13109114